Chemoinformaics analysis of THIAZOLIDINE-4-CARBOXYLIC ACID
Molecular Weight | 133.172 | nRot | 1 |
Heavy Atom Molecular Weight | 126.116 | nRig | 6 |
Exact Molecular Weight | 133.02 | nRing | 1 |
Solubility: LogS | -1.758 | nHRing | 1 |
Solubility: LogP | -1.974 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 4 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 16.9516 |
nHD | 2 | BPOL | 10.9204 |
QED | 0.517 |
Synth | 3.533 |
Natural Product Likeliness | 0.52 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.01 |
CACO-2 | -5.893 |
MDCK | 0.00000353 |
BBB | 0.522 |
PPB | 0.0786613 |
VDSS | 0.592 |
FU | 0.908594 |
CYP1A2-inh | 0.013 |
CYP1A2-sub | 0.089 |
CYP2c19-inh | 0.034 |
CYP2c19-sub | 0.061 |
CYP2c9-inh | 0.035 |
CYP2c9-sub | 0.74 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.352 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.027 |
CL | 4.838 |
T12 | 0.81 |
hERG | 0.013 |
Ames | 0.008 |
ROA | 0.045 |
SkinSen | 0.384 |
Carcinogencity | 0.471 |
EI | 0.718 |
Respiratory | 0.387 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.946707 |